All Stories

  1. Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation

    Article • Journal of the American Heart Association, May 2020, Wolters Kluwer Health

    Mr Robert A Overman

  2. Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

    Article • Clinical Epidemiology, May 2020, Taylor & Francis

    Mr Robert A Overman

  3. Trends in Chronic Opioid Use Around Inpatient Surgery Within the Veterans Health Administration

    Article • JAMA Surgery, December 2019, American Medical Association (AMA)

    Mr Robert A Overman

  4. Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty

    Article • Anesthesiology, August 2019, Wolters Kluwer Health

    Mr Robert A Overman

  5. Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

    Article • Cancer Medicine, December 2018, Wiley

    Mr Robert A Overman

  6. Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

    Article • Clinical Epidemiology, September 2018, Dove Medical Press

    Mr Robert A Overman

  7. Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States

    Article • Pharmacoepidemiology and Drug Safety, January 2018, Wiley

    Mr Robert A Overman

  8. Correction to: Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study

    Article • Archives of Osteoporosis, November 2017, Springer Science + Business Media

    Mr Robert A Overman

  9. Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study

    Article • Archives of Osteoporosis, October 2017, Springer Science + Business Media

    Mr Robert A Overman

  10. Target weight achievement and ultrafiltration rate thresholds: potential patient implications

    Article • BMC Nephrology, June 2017, Springer Science + Business Media

    Mr Robert A Overman

  11. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

    Article • Rheumatology, March 2017, Oxford University Press (OUP)

    Mr Robert A Overman

  12. Time to clinically relevant fracture risk scores in postmenopausal women

    Article • The American Journal of Medicine, March 2017, Elsevier

    Mr Robert A Overman

  13. Cost and Cost-effectiveness Analysis of Treatment Options for Sanders II and III Calcaneus Fractures In Laborers

    Article • Journal of Orthopaedic Trauma, January 2017, Wolters Kluwer Health

    Mr Robert A Overman

  14. Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer

    Article • American Journal of Men s Health, July 2016, SAGE Publications

    Mr Robert A Overman

  15. Time to Osteoporosis and Major Fracture in Older Men

    Article • American Journal of Preventive Medicine, June 2016, Elsevier

    Mr Robert A Overman

  16. Global Experiential and Didactic Education Opportunities at US Colleges and Schools of Pharmacy

    Article • American Journal of Pharmaceutical Education, February 2016, American Journal of Pharmaceutical Education

    Mr Robert A Overman

  17. Bone Density Screening and Re-screening in Postmenopausal Women and Older Men

    Article • Current Osteoporosis Reports, September 2015, Springer Science + Business Media

    Mr Robert A Overman

  18. Evaluating Indeterminate Interferon-γ-Release Assay Results in Patients With Chronic Inflammatory Diseases Receiving Immunosuppressive Therapy

    Article • Arthritis Care & Research, July 2015, Wiley

    Mr Robert A Overman

  19. Baseline age and time to major fracture in younger postmenopausal women

    Article • Menopause The Journal of The North American Menopause Society, June 2015, Wolters Kluwer Health

    Mr Robert A Overman

  20. DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women

    Article • Journal of Clinical Densitometry, April 2015, Elsevier

    Mr Robert A Overman

  21. Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis

    Article • Osteoporosis International, January 2015, Springer Science + Business Media

    Mr Robert A Overman

  22. United States Adults Meeting 2010 American College of Rheumatology Criteria for Treatment and Prevention of Glucocorticoid-Induced Osteoporosis

    Article • Arthritis Care & Research, October 2014, Wiley

    Mr Robert A Overman

  23. Observation stays in administrative claims databases: underestimation of hospitalized cases

    Article • Pharmacoepidemiology and Drug Safety, May 2014, Wiley

    Mr Robert A Overman

  24. Salmon Calcitonin Use and Associated Cancer Risk

    Article • Annals of Pharmacotherapy, October 2013, SAGE Publications

    Mr Robert A Overman

  25. Prevalence of oral glucocorticoid usage in the United States: A general population perspective

    Article • Arthritis Care & Research, January 2013, Wiley

    Mr Robert A Overman